Glaucoma in the Real World

Early-stage #glaucoma isn’t a “one-and-done” decision, it’s a lifelong journey. Experts Zarmeena Vendal MD, Manjool Shah, MD, Lorraine Provencher, MD, Paul Singh, MD, Emily Schehlein, MD and Swarup Swaminathan, MD discus real-world challenges like drop adherence, ocular surface disease, and cumulative exposure matter. When nearly 80% of patients struggle with proper drop use, it forces us to rethink how #SLT and sustained-release therapies may work together earlier in the treatment algorithm. The question isn’t if we need multiple tools, it’s when and how we use them. 📘Need CE Crediits? Explore the Early-Stage Glaucoma Detection educational series and monograph by The Fundingsland Group tfgeducation.com/resources/early-stage-glaucoma-detection-monograph-video/